Browse by ["viewname_eprint_publisher" not defined]

A

Aicher, Babette and Schuster, Tilmann and Blumenstein, Lars and Schubert, Antje and Gruendker, Carsten and Engel, Joerg B. and Ortmann, Olaf and Mueller, Rolf and Guenther, Eckhard and Gerlach, Matthias and Teifel, Michael (2013) LHRH receptor targeting as mechanism of anti-tumor activity for cytotoxic conjugates of Disorazol Z with the LHRH receptor agonistic peptide D-Lys6-LHRH. AMER ASSOC CANCER RESEARCH, PHILADELPHIA.

B

Brockhoff, G. and Machleidt, A. and Piendl, G. and Seegers, S. and Sassen, A. and Diermeier-Daucher, S. and Buchholz, S. and Ortmann, O. (2011) HER4 Coexpression Is Associated with Improved Recurrence EFree Survival in HER2-Positive, Herceptin Treated Patients. CANCER RESEARCH, 71 (24Supp): P1-12-23. ISSN 0008-5472, 1538-7445

Buchholz, S. and Koester, F. and Schally, A. and Krishan, A. and Papadia, A. and Ortmann, O. and Seitz, S. (2009) Combination of a Novel Growth Hormone Releasing Hormone Antagonist JMR 132 and Tamoxifen Enhances the Inhibitory Effects on Growth of ZR 75 and T47D Estrogen Dependent Human Breast Cancer Cells In Vitro and In Vivo. In: 32nd Annual San Antonio Breast Cancer Symposium, DEC 09-13, 2009, San Antonio, TX.

D

Dreyer, Tobias F. and Kuhn, Sabine and Stange, Christoph and Heithorst, Nadine and Schilling, Daniela and Jelsma, Jil and Sievert, Wolfgang and Seitz, Stefanie and Stangl, Stefan and Hapfelmeier, Alexander and Noske, Aurelia and Wege, Anja K. and Weichert, Wilko and Ruland, Juergen and Schmitt, Manfred and Dorn, Julia and Kiechle, Marion and Reuning, Ute and Magdolen, Viktor and Multhoff, Gabriele and Bronger, Holger (2021) The Chemokine CX3CL1 Improves Trastuzumab Efficacy in HER2 Low-Expressing Cancer In Vitro and In Vivo. CANCER IMMUNOLOGY RESEARCH, 9 (7). pp. 779-789. ISSN 2326-6066, 2326-6074

E

Eggemann, Holm and Brucker, Cosima and Schirrmeister, Susen and Ringsdorf, Uta and Augustin, Doris and Schrauder, Michael and Thill, Marc and Flock, Felix and Kraudelt, Susanne and Gad, Gabriele and Kleine-Tebbe, Anke and Reinisch, Mattea and Costa, Serban-Dan and Ignatov, Atanas (2020) Treatment strategies in male breast cancer: Results of a prospective multicenter study. In: San Antonio Breast Cancer Symposium, DEC 10-14, 2019, San Antonio, TX.

Engel, J. B. and Schreiber, A. and Seitz, S. and Koester, F. and Kaemmerer, U. and Dietl, J. and Honig, A. (2009) Triple-Negative Breast Cancers Express Receptors for GnRH and Can Be Effectively Targeted by the Orally Active GnRH-Antagonist AEZS 115. In: 32nd Annual San Antonio Breast Cancer Symposium, DEC 09-13, 2009, San Antonio, TX.

F

Fehm, T. and Mueller, V and Kasimir-Bauer, S. and Janni, W. and Loehberg, C. and Gebauer, G. and Rack, B. and Stickeler, E. and Ortmann, O. and Riethdorf, S. and Solomayer, E. and Klein, C. and Schindlbeck, C. and Kreipe, H. and Wallwiener, D. and Pantel, K. (2009) Detect-Study: Comparison of Two Techniques for the Evaluation of the HER2 Expression on Circulating Tumor Cells in Metastatic Breast Cancer. In: 32nd Annual San Antonio Breast Cancer Symposium, DEC 09-13, 2009, San Antonio, TX.

H

Honig, A. and Martens, T. and Haeusler, S. and Buchholz, S. and Rack, B. and Wishhusen, J. and Dietl, J. and Engel, J. B. (2009) Antitumoral Activity of 3rd Generation Derivative Lobaplatin in In Vitro Models of Triple-Negative Breast Cancers. In: 32nd Annual San Antonio Breast Cancer Symposium, DEC 09-13, 2009, San Antonio, TX.

K

Kotzur, Franziska and Bidner, Helen and Bronger, Holger and Egert, Silvia and Fasching, Peter A. and Fischer, Dorothea and Kehl, Victoria and Lück, Hans-Joachim and Müller, Lothar and Reuning, Ute and Rief, Lukas and Rösch, Romina and Seitz, Stephan and Winter, Christof and Kiechle, Marion and Ettl, Johannes (2021) ABEMACARE: Abemaciclib in combination with endocrine therapy as first line therapy in metastatic breast cancer patients with symptomatic visceral metastases or high tumor burden. In: 2020 San Antonio Breast Cancer Virtual Symposium, December 8-11, 2020, San Antonio, Texas.

Krefft, Anya and Eberhardt, Andrea and Oruzio, Daniel and Hartmann, Claudia and Laberer, Hans and Appel, Inka and Brockhoff, Gero and Klein, Christoph (2009) Identification of two putative tumor suppressor genes involved in early dissemination of breast cancer. CANCER RESEARCH, 69 (9suppl): 5333. ISSN 0008-5472, 1538-7445

L

Lux, M. P. and Benedict, A. and Buchholz, S. and Woeckel, A. and Harbeck, N. and Kreienberg, R. and Kaufmann, M. and Beckmann, M. W. and Jonat, W. and Hadji, P. and Distler, W. and Raab, G. and Tesch, H. and Weyers, G. and Schneeweiss, A. and Possinger, K. (2009) Cost-effectiveness of anastrozole versus tamoxifen as adjuvant therapy in early breast cancer (EBC) - a German health economic analysis. In: 31st Annual San Antonio Breast Cancer Symposium, December 10-14, 2008, San Antonio, TX.

N

Neven, P. and Donders, G. and Moegele, M. and Lintermans, A. and BeIlen, G. and Ortmann, O. and Buchholz, S. (2012) Ultra-low dose vaginal estriol and Lactobacillus acidophilus (Gynoflo (R)) in early breast cancer survivors on aromatase inhibitors: Pharmacokinetic, efficacy and safety results from a phase I study. CANCER RESEARCH, 72 (24Supp): P2-12-06. ISSN 0008-5472, 1538-7445

S

Seitz, S. and Schally, A. and Papadia, A. and Glueck, S. and Calfa, C. and Ortmann, O. and Buchholz, S. (2009) Effective tumor growth inhibition of MX1 and MDA-MB-231 estrogen receptor negative human breast cancer xenografts by treatment with LHRH antagonist cetrorelix. In: 31st Annual San Antonio Breast Cancer Symposium, December 10-14, 2008, San Antonio, TX.

Springwald, A. and Lattrich, C. R. and Ortmann, O. and Treeck, O. (2009) Estrogen Receptor beta Exerts Growth-Inhibitory Effects on Human Mammary Epithelial Cells. In: 32nd Annual San Antonio Breast Cancer Symposium, DEC 09-13, 2009, San Antonio, TX.